![]() |
![]() |
Legal status
Patent in force
(51) | INT.CL. | A61K 39/00 | (2006.01) |
A61K 39/35 | (2006.01) | ||
A61K 45/06 | (2006.01) | ||
A61K 39/39 | (2006.01) |
(11) | Number of the document | 2486938 |
(13) | Kind of document | T |
(96) | European patent application number | 12153256.8 |
Date of filing the European patent application | 2007-09-26 | |
(97) | Date of publication of the European application | 2012-08-15 |
(45) | Date of publication and mention of the grant of the patent | 2018-05-09 |
(46) | Date of publication of the claims translation | 2018-06-25 |
(30) | Number | Date | Country code |
847404 P | 2006-09-26 | US |
(72) |
Reed, Steven G., US
Carter, Darrick, US
|
(73) |
Infectious Disease Research Institute,
1616 Eastlake Ave. E Suite 400, Seattle, WA 98102,
US
|
(74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
(54) | Vakcinos kompozicija, turinti sintetinio adjuvanto |
Vaccine composition containing synthetic adjuvant |
Payment date | Validity (years) | Amount | |
2024-08-09 | 18 | 347.00 EUR |
2025-09-26 |